Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Relapsed Solid Tumors × Cefixime × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neuroblastoma 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Solid Tumors 1 Solid Tumor 1 Relapsed Solid Tumors 1 Drug-Related Side Effects and Adverse Reactions 1 Diarrhea 1

Interventions

eribulin 1 Irinotecan 1 Cefixime 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02596503 2022-02-15

A Study of Eribulin in Combination With Oral Irinotecan for Adolescent and Young Adult Patients With Relapsed or Refractory Solid Tumors

University of Colorado, Denver

Phase 1 Completed

Other solid neoplasm

Relapsed Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡